Gary M. Bokoch, the Rac-n-Rho Man: His Fascination with Rho-GTPases
NADPH Oxidases Revisited: From Function to Structure, Page: 123-132
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Dr. Gary Bokoch’s legacy (Fig. 8.1) continues in each of us who learned about RhoGTPases through his training, publications, collaborations, and presentations. His expertise on RhoGTPases provided the root for the branches of his studies into fields such as chemotaxis, the actin cytoskeleton, p-21 activated kinases, LIM kinase, and NADPH oxidases. A survey of his 217 publications from his graduate work to his final days as professor clearly showed that the topic of neutrophils was special to him since that is how his successful scientific career began. From working on arachidonic metabolism in guinea pig neutrophils during graduate school, to identifying the Gialpha (Giα)-subunit while a post-doc in the laboratory of Nobel Laureate, Dr. Alfred Gilman, to discovering functions for RhoGTPases in NOX2 in neutrophils, Dr. Bokoch’s dedication to this field has taught us how to approach studies on signaling mechanisms applicable to many areas of science. I hope my presentation of Dr. Bokoch (Gary as I shall address him hereon) will paint a vivid picture of his journeys that led him to the path of NADPH Oxidases. As for the many other scientific paths on which he traveled, they would each require a separate chapter.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85170998362&origin=inward; http://dx.doi.org/10.1007/978-3-031-23752-2_8; https://link.springer.com/10.1007/978-3-031-23752-2_8; https://dx.doi.org/10.1007/978-3-031-23752-2_8; https://link.springer.com/chapter/10.1007/978-3-031-23752-2_8
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know